Who We Are
Since 1955, the NKF of Michigan, Inc. (NKFM) has led the fight against these life-threatening diseases. We have enhanced the lives of many Michigan residents through our patient services, research and education programs. Our efforts have also changed legislation, ensured quality care for patients and advanced medical knowledge. We have informed the public about kidney and urological diseases and increased awareness of the critical need for organ and tissue donations.
Our Mission
To prevent kidney disease and improve the quality of life for those living with it.
Our Guiding Principles
- Prevent chronic kidney disease (CKD) and its leading causes; diabetes and high blood pressure
- Pursue funding in support of our mission
- Advocate for people living with and at risk of CKD
- Promote quality of care for people with CKD, diabetes and hypertension
- Educate the public about CKD, diabetes, hypertension and obesity
- Promote organ and tissue donation
- Support research of CKD
NKF of Michigan, Inc. Board of Directors
Executive Committee
Cynthia H. Shannon *
Chairman
Daniel M. Carney *
President and CEO
Mark E. Behm *
Vice Chairman
M. David Campbell *
Immediate Past Chair and Secretary
Officers (Non-Executive Committee)
Andrew Boschma *
Treasurer
Michael Allie
Renee T. Farhat
Janice G. Frazier
Sen. Beverly S. Hammerstrom
Hon. Kirsten Frank Kelly **
Tomasine Marx
David W. Potts
Robert Provenzano, M.D. **
Scott Seling
Michael S. Sisskind
* Executive Committee
** Ex-Officio
NKF of Michigan, Inc. Scientific Advisory Board
Jerry Yee M.D., Chair
Keith Bellovich M.D., Past Chair
Will Beierwaltes M.D., Research Chair
Mary Stapleton, Patient Services Chair
Joseph L. Blount M.D.
Jean Chabut
Paul Dake
Andrea DeKam, LMSW
Hassan Fehmi, M.D.
Crystal A. Gadegbeku M.D.
Mary Ellen Larson M.D.
John Magee M.D.
Tej K. Mattoo M.D.
Timothy McDonald M.D.
Silas Norman, M.D
Paul Ponstein M.D.
Noreen Rossi, M.D.
Thomas Ruane M.D.
Rajiv Saran M.D.
Elisea Singson M.D.
Our Founder
On November 15, 1950, Mr. and Mrs. Harry DeBold called the first meeting of the Committee for Nephrosis Research. Several months earlier, Mrs. DeBold’s infant son was stricken with nephrosis, a condition of which little was known and for which little could be done. Her determination not to succumb to the grim reality of her son’s disease and her affluence and wealth were important elements which led to the formation of the inaugural lay group destined to becomeThe National Kidney Foundation. The Ada DeBold Society was created to help ensure the philanthropic future of the NKF in honor of Mrs. Ada U. DeBold.
By sharing their financial resources and publicly expressing their support, members of The Ada DeBold Society address NKF’s mission to prevent kidney and urinary tract diseases, improve the health and well-being of individuals and families affected by these diseases, and increase the availability of all organs for transplantation. This framework of support helps the NKF plan for the present and look to the future. More information about The Ada DeBold Society.
